Lexaria Bioscience Corp. (LEXX) — Gross Profit

Annual figures by fiscal year, from SEC filings.

2010: $88.9K2011: $465.9K2012: $574.5K2013: $302.3K2014: $02015: -$15.2K2016: -$4.9K2017: $33.9K2018: $408.1K2019: $199.7K2020: $215.4K2021: $547.4K2022: $183.6K2023: $194.7K2024: $459.5K2025: $703.2K$703.2K
2010Gross Profit (USD)2025
Fiscal YearGross ProfitChange YoY
2025$703.2K+53.1%
2024$459.5K+136.0%
2023$194.7K+6.1%
2022$183.6K-66.5%
2021$547.4K+154.1%
2020$215.4K+7.9%
2019$199.7K-51.1%
2018$408.1K+1104.2%
2017$33.9K+792.0%
2016-$4.9K+67.7%
2015-$15.2K
2014$0-100.0%
2013$302.3K-47.4%
2012$574.5K+23.3%
2011$465.9K+424.3%
2010$88.9K